252 related articles for article (PubMed ID: 33095414)
1. Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.
Xu GB; Guan PP; Wang P
Mol Neurobiol; 2021 Mar; 58(3):1114-1127. PubMed ID: 33095414
[TBL] [Abstract][Full Text] [Related]
2. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
[TBL] [Abstract][Full Text] [Related]
3. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
4. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
5. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
6. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
7. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
8. S-Adenosylmethionine Rescues Cognitive Deficits in the rTg4510 Animal Model by Stabilizing Protein Phosphatase 2A and Reducing Phosphorylated Tau.
Beauchamp LC; Liu XM; Sedjahtera A; Bogeski M; Vella LJ; Bush AI; Adlard PA; Barnham KJ
J Alzheimers Dis; 2020; 77(4):1705-1715. PubMed ID: 32925070
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms.
Xu GB; Yang LQ; Guan PP; Wang ZY; Wang P
Neurotherapeutics; 2019 Apr; 16(2):505-522. PubMed ID: 30627958
[TBL] [Abstract][Full Text] [Related]
10. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
11. Nmnat2 attenuates Tau phosphorylation through activation of PP2A.
Cheng XS; Zhao KP; Jiang X; Du LL; Li XH; Ma ZW; Yao J; Luo Y; Duan DX; Wang JZ; Zhou XW
J Alzheimers Dis; 2013; 36(1):185-95. PubMed ID: 23579329
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation.
Luo DJ; Feng Q; Wang ZH; Sun DS; Wang Q; Wang JZ; Liu GP
J Neurochem; 2014 Sep; 130(6):816-25. PubMed ID: 24821282
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 is Essential for Mediating the Effects of Calcium Ions on Stimulating Phosphorylation of Tau at the Sites of Ser 396 and Ser 404.
Cao LL; Guan PP; Liang YY; Huang XS; Wang P
J Alzheimers Dis; 2019; 68(3):1095-1111. PubMed ID: 30883354
[TBL] [Abstract][Full Text] [Related]
14. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
15. Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
Hu W; Wang Z; Zhang H; Mahaman YAR; Huang F; Meng D; Zhou Y; Wang S; Jiang N; Xiong J; Westermarck J; Lu Y; Wang J; Wang X; Shentu Y; Liu R
Neurotherapeutics; 2022 Mar; 19(2):570-591. PubMed ID: 35286657
[TBL] [Abstract][Full Text] [Related]
16. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells.
Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H
Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538
[TBL] [Abstract][Full Text] [Related]
17. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
[TBL] [Abstract][Full Text] [Related]
18. SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments.
Qin M; Li H; Bao J; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Shu X; Wang X
Acta Neuropathol Commun; 2019 Feb; 7(1):21. PubMed ID: 30767764
[TBL] [Abstract][Full Text] [Related]
19. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice.
Kins S; Crameri A; Evans DR; Hemmings BA; Nitsch RM; Gotz J
J Biol Chem; 2001 Oct; 276(41):38193-200. PubMed ID: 11473109
[TBL] [Abstract][Full Text] [Related]
20. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
Arribas RL; Viejo L; Bravo I; Martínez M; Ramos E; Romero A; García-Frutos EM; Janssens V; Montiel C; de Los Ríos C
Eur J Med Chem; 2023 May; 251():115245. PubMed ID: 36905916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
